Spartina Biotechnologies


Our Team

Executive Leadership

Paul Laur

CEO, Co-Founder, & Board Director

Paul Laur co-founded Spartina Biotechnologies in 2015. His previous companies include Eldorado Biofuels, in which he built a prototype algae to biofuels facility as PI in the  National Alliance of Advanced Biofuels and Bioproducts, and Santa Fe Cider Company. Paul was Director of Operations at Anguilla Rums, and Director of Corporate Development at Pebble Labs where he brought in over $4 million dollars in Economic Development funding.

Paul holds a USCG Master Mariner’s license and a Master’s Degree from St. John’s College. He currently serves on the Boards of the NM Biotechnology and Biomedical Association and Ponderous Panda Capital Corporation.

Richard Sayre, Ph.D.

Inventor & Consultant

Dr. Sayre is a molecular biologist and co- inventor of Siren technology. He was voted one of the world’s most influential scientists by Nature Magazine. Dr. Sayre is also Sr. Research Scientist at the New Mexico Consortium and President of Richard Sayre Consulting.

Science Team

Tanya Vinogradova Shah, Ph.D.

Research Director

Dr. Vinogradova Shah is co-inventor of Siren technology. An expert in molecular biology, molecular cloning, genetics, and bacterial genome editing. She also has expertise in RNAi applications for gene silencing in bacteria, invertebrates, plants and mammalian cell cultures. Tatiana is author of 12 scientific papers and 7 patents (issued and pending).

Wataru Nishima, Ph.D.

Bioinformatics Scientist

Dr. Wataru has investigated biological systems including T4 phage infection, multi-drug resistance, Ebola/Zika virus transition, cytokine/ enzyme design, mRNA-tRNA translocation, using statistical/sequence analysis, and computational protein design. He also developed methodologies to characterize protein/glycan conformational changes. 

Alexandre V. Pertzev, Ph.D.


Dr. Pertzev has diverse experience in nucleic-protein, protein-protein and enzyme-ligand interactions, regulation of gene expression and cell function, protein structure and function, evolution transfer and prevalence of genes, DNA and RNA modifying proteins and protein engineering. He also has expertise include microbiology, immunology, and molecular and cell biology.


Todd Buck, PhD.

Mintz | Patent Counsel

Dr. Buck is a seasoned patent prosecutor and portfolio manager for Mintz. His practice includes portfolio strategies, preparing and prosecuting patent applications & licensing transactions. He represents  pharma and biotech clients in IP & FDA laws.

Scientific Advisory Board

Stephen Hedrick, Ph.D.


Dr. Hedrick is a molecular biologist with a wealth of experience in the field of immunology and a unique insight into the understanding of how immune systems in organisms evolve in concert with pathogens. His research work focuses on the regulation of the immune system including cell death, signal transduction, and evolution.

Jack Lewin, MD


Dr. Lewin is Chairman of the National Coalition on Health and CEO of Convergent Health Systems, a leading provider of advanced risk-mitigation strategies related to the Covid-19 pandemic. He has advised two Presidents of the United States on health care and public policy.

Board of Directors

Steve Kiziuk

Board Director

Founder and President of Mountain Vector Energy, Albuquerque, NM

Dr. Steven Buelow

Board Director

Executive Director of the New Mexico Consortium, Los Alamos, NM